Related references
Note: Only part of the references are listed.Circadian clocks and energy metabolism
Gencer Sancar et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Partial Reversal of Skeletal Muscle Aging by Restoration of Normal NAD+ Levels
Andrew R. Mendelsohn et al.
REJUVENATION RESEARCH (2014)
SIRT1 Mediates Central Circadian Control in the SCN by a Mechanism that Decays with Aging
Hung-Chun Chang et al.
CELL (2013)
GPR109A and Vascular Inflammation
Joshua T. Chai et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Light-dark condition regulates sirtuin mRNA levels in the retina
Norimitsu Ban et al.
EXPERIMENTAL GERONTOLOGY (2013)
Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease (vol 12, pg 469, 2013)
B. F. Boeve
LANCET NEUROLOGY (2013)
Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's disease
Lama M. Chahine et al.
MOVEMENT DISORDERS (2013)
Circadian Clock NAD+ Cycle Drives Mitochondrial Oxidative Metabolism in Mice
Clara Bien Peek et al.
SCIENCE (2013)
Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease
Bradley F. Boeve
LANCET NEUROLOGY (2013)
Anti-Inflammatory Effects of Nicotinic Acid in Human Monocytes Are Mediated by GPR109A Dependent Mechanisms
Janet E. Digby et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder
R. B. Postuma et al.
BRAIN (2012)
Minireview: NAD+, a Circadian Metabolite with an Epigenetic Twist
Paolo Sassone-Corsi
ENDOCRINOLOGY (2012)
Diagnostic value of the rapid assessment of postural instability in parkinson's disease (RAPID) questionnaire
R. K. Y. Chong et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results
David Hasan et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Sleep and Parkinson's Disease: A Review of Case-Control Polysomnography Studies
Tasneem Peeraully et al.
MOVEMENT DISORDERS (2012)
Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Min Han et al.
PLOS ONE (2012)
Crosstalk between Components of Circadian and Metabolic Cycles in Mammals
Gad Asher et al.
CELL METABOLISM (2011)
Rapid assessment of postural instability in Parkinson's disease (RAPID): a pilot study
R. K. Y. Chong et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Associated factors for REM sleep behavior disorder in Parkinson disease
Friederike Sixel-Doering et al.
NEUROLOGY (2011)
Potential beneficial effects of butyrate in intestinal and extrainitestinal diseases
Roberto Berni Canani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Toby Lawrence et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin
Janet E. Digby et al.
ATHEROSCLEROSIS (2010)
NAD: A master regulator of transcription
Sanchari Ghosh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Clocks in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and aging
Shin-ichiro Imai
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Mitochondrial Metabolism Modulation: A New Therapeutic Approach for Parkinson's Disease
D. M. Arduino et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Mammalian circadian clock and metabolism - the epigenetic link
Marina Maria Bellet et al.
JOURNAL OF CELL SCIENCE (2010)
Delayed reduction in hippocampal postsynaptic density protein-95 expression temporally correlates with cognitive dysfunction following controlled cortical impact in mice
Chandramohan Wakade et al.
JOURNAL OF NEUROSURGERY (2010)
Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer
Brittney Jung-Hynes et al.
JOURNAL OF PINEAL RESEARCH (2010)
Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells
Shobha H. Ganji et al.
ATHEROSCLEROSIS (2009)
Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord
Kristina A. Kigerl et al.
JOURNAL OF NEUROSCIENCE (2009)
Nicotinic acid: Pharmacological effects and mechanisms of action
Andreas Gille et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism
D. W. Anderson et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease
S. Crotty et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease
Haiqun Jia et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Niaspan increases angiogenesis and improves functional recovery after stroke
Jieli Chen et al.
ANNALS OF NEUROLOGY (2007)
Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+
Peter Belenky et al.
CELL (2007)
Cross-cultural evaluation of the short form 8-item Parkinson's disease questionnaire (PDQ-8): Results from America, Canada, Japan, Italy and Spain
Crispin Jenkinson et al.
PARKINSONISM & RELATED DISORDERS (2007)
The natural history of Parkinson's disease
Werner Poewe
JOURNAL OF NEUROLOGY (2006)
Langerhans cells release prostaglandin D2 in response to nicotinic acid
Dominique Maciejewski-Lenoir et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat
Michael R. Hoane et al.
JOURNAL OF NEUROTRAUMA (2006)
Preadaptation to efficient respiratory maintenance is essential both for maximal longevity and the retention of replicative potential in chronologically ageing yeast
Peter W. Piper et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2006)
Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy
Yo Sasaki et al.
JOURNAL OF NEUROSCIENCE (2006)
The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target
Stefan Offermanns
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Niacin improved rigidity and bradykinesia in a Parkinson's disease patient but also caused unacceptable nightmares and skin rash - A case report
JM Alisky
NUTRITIONAL NEUROSCIENCE (2005)
(D)-β-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G
AKP Taggart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations
CG Goetz et al.
MOVEMENT DISORDERS (2004)
The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations
CG Goetz et al.
MOVEMENT DISORDERS (2003)
The Parkinson's disease sleep scale:: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease
KR Chaudhuri et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
D-β-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease
Y Kashiwaya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Butyrate inhibits inflammatory responses through NF kappa B inhibition: implications for Crohn's disease
JP Segain et al.
GUT (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
